FI906438L - Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI906438L FI906438L FI906438A FI906438A FI906438L FI 906438 L FI906438 L FI 906438L FI 906438 A FI906438 A FI 906438A FI 906438 A FI906438 A FI 906438A FI 906438 L FI906438 L FI 906438L
- Authority
- FI
- Finland
- Prior art keywords
- steroid
- carboxylic acid
- acid derivatives
- therapeutically useful
- preparing novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45886989A | 1989-12-29 | 1989-12-29 | |
| US45886989 | 1989-12-29 | ||
| US58075990 | 1990-09-11 | ||
| US07/580,759 US5100917A (en) | 1989-12-29 | 1990-09-11 | Novel a-nor-steroid-3-carboxylic acid derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI906438A0 FI906438A0 (fi) | 1990-12-28 |
| FI906438L true FI906438L (fi) | 1991-06-30 |
| FI94418B FI94418B (fi) | 1995-05-31 |
| FI94418C FI94418C (fi) | 1995-09-11 |
Family
ID=27039140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI906438A FI94418C (fi) | 1989-12-29 | 1990-12-28 | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5100917A (fi) |
| EP (1) | EP0435321B1 (fi) |
| JP (1) | JP3039996B2 (fi) |
| KR (3) | KR0178468B1 (fi) |
| CN (4) | CN1033809C (fi) |
| AT (1) | ATE126232T1 (fi) |
| AU (1) | AU634326B2 (fi) |
| CA (1) | CA2033392C (fi) |
| DE (1) | DE69021530T2 (fi) |
| DK (1) | DK0435321T3 (fi) |
| ES (1) | ES2078291T3 (fi) |
| FI (1) | FI94418C (fi) |
| GR (1) | GR3017559T3 (fi) |
| HU (1) | HU210340B (fi) |
| IE (1) | IE67511B1 (fi) |
| IL (1) | IL96790A (fi) |
| MX (1) | MX9203338A (fi) |
| NO (1) | NO180719C (fi) |
| NZ (1) | NZ236589A (fi) |
| PT (1) | PT96394B (fi) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2126203A1 (en) * | 1991-12-20 | 1993-07-08 | Stephen V. Frye | Inhibitors of 5-alpha-testosterone reductase |
| HUT71514A (en) * | 1992-05-21 | 1995-12-28 | Endorecherche Inc | Inhibitors of testosterone 5 alfa-reductase activity and pharmaceutical compositions containing the same |
| US5302589A (en) * | 1992-08-07 | 1994-04-12 | Glaxo, Inc. | Heterocyclic inhibitors of 5-α-testosterone reductase |
| US5561124A (en) * | 1992-11-18 | 1996-10-01 | Webb; Robert L. | 17-α-acyl steroids which inhibit 5-α-reductase |
| GB9224148D0 (en) * | 1992-11-18 | 1993-01-06 | Smithkline Beecham Corp | Compounds |
| TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| US5541322A (en) * | 1994-10-14 | 1996-07-30 | Glaxo Wellcome Inc. | Synthesis of 6-azaandrostenones |
| US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US8119109B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US7704518B2 (en) * | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US9668972B2 (en) * | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| FR2857968B1 (fr) * | 2003-07-25 | 2006-02-03 | Inovat Sarl | Nouveaux derives steroides et leurs utilisations therapeuthique |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| BRPI0612448A2 (pt) * | 2005-05-09 | 2010-11-23 | Foamix Ltd | composição espumosa de sacarìdeo |
| US20080152596A1 (en) * | 2005-07-19 | 2008-06-26 | Foamix Ltd. | Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
| US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| WO2009007785A2 (en) * | 2006-11-14 | 2009-01-15 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| CA2712120A1 (en) * | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| JP5527236B2 (ja) * | 2011-01-31 | 2014-06-18 | 信越化学工業株式会社 | ポジ型化学増幅レジスト材料、パターン形成方法及び酸分解性ケトエステル化合物 |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3336338A (en) * | 1963-09-13 | 1967-08-15 | Squibb & Sons Inc | A-nor-cholestatriene-21-oic acid 21->24 lactones |
| US3600425A (en) * | 1963-09-13 | 1971-08-17 | Squibb & Sons Inc | Synthesis of steroids |
| US3484476A (en) * | 1963-09-13 | 1969-12-16 | Squibb & Sons Inc | A-nor steroids |
| US3424751A (en) * | 1965-10-20 | 1969-01-28 | Du Pont | Selected 2-formyl-and 2alpha-(cyanoamidino)-a-nor-5alpha-androstane derivatives |
| US3492359A (en) * | 1966-01-14 | 1970-01-27 | Squibb & Sons Inc | 11,12-oxo and/or oxy substituted a-norpregnenes |
| US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
-
1990
- 1990-09-11 US US07/580,759 patent/US5100917A/en not_active Expired - Fee Related
- 1990-12-21 NZ NZ236589A patent/NZ236589A/xx unknown
- 1990-12-26 IL IL9679090A patent/IL96790A/en not_active IP Right Cessation
- 1990-12-27 NO NO905608A patent/NO180719C/no not_active IP Right Cessation
- 1990-12-27 CN CN90110188A patent/CN1033809C/zh not_active Expired - Fee Related
- 1990-12-27 AU AU68447/90A patent/AU634326B2/en not_active Ceased
- 1990-12-28 DE DE69021530T patent/DE69021530T2/de not_active Expired - Fee Related
- 1990-12-28 FI FI906438A patent/FI94418C/fi not_active IP Right Cessation
- 1990-12-28 DK DK90125681.8T patent/DK0435321T3/da active
- 1990-12-28 HU HU908495A patent/HU210340B/hu not_active IP Right Cessation
- 1990-12-28 IE IE472090A patent/IE67511B1/en not_active IP Right Cessation
- 1990-12-28 EP EP90125681A patent/EP0435321B1/en not_active Expired - Lifetime
- 1990-12-28 AT AT90125681T patent/ATE126232T1/de not_active IP Right Cessation
- 1990-12-28 KR KR1019900023009A patent/KR0178468B1/ko not_active Expired - Fee Related
- 1990-12-28 PT PT96394A patent/PT96394B/pt not_active IP Right Cessation
- 1990-12-28 ES ES90125681T patent/ES2078291T3/es not_active Expired - Lifetime
- 1990-12-28 CA CA002033392A patent/CA2033392C/en not_active Expired - Fee Related
- 1990-12-28 JP JP2415397A patent/JP3039996B2/ja not_active Expired - Fee Related
-
1992
- 1992-06-29 MX MX9203338A patent/MX9203338A/es unknown
-
1994
- 1994-12-21 CN CN94119555A patent/CN1127256A/zh active Pending
- 1994-12-21 CN CN94119557A patent/CN1127258A/zh active Pending
- 1994-12-21 CN CN94119556A patent/CN1036200C/zh not_active Expired - Fee Related
-
1995
- 1995-09-28 GR GR950402672T patent/GR3017559T3/el unknown
-
1998
- 1998-09-29 KR KR1019980040652A patent/KR0178471B1/ko not_active Expired - Fee Related
- 1998-09-29 KR KR1019980040651A patent/KR0178470B1/ko not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI906438L (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
| FI885409A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi | |
| FI883249A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi | |
| FI890282L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| PT88596A (pt) | Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas | |
| FI881180L (fi) | Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi | |
| FI892881A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi | |
| FI905941A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi | |
| FI882638L (fi) | Menetelmä terapeuttisesti käyttökelpoisten booriaminohappojohdannaisten valmistamiseksi | |
| FI893467L (fi) | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi | |
| FI880816A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi | |
| FI883050L (fi) | Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi | |
| FI894217L (fi) | 1-adamantaanijohdannaisten valmistusmenetelmä | |
| FI883632L (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten eetterien valmistamiseksi | |
| FI873350A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI883603A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI884627A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten dideoksisytidiinijohdannaisten valmistamiseksi | |
| FI880467A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| FI883672A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi | |
| FI884910A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi | |
| FI881525A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi | |
| FI885560A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
| FI893003L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
| FI884660L (fi) | Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi | |
| FI906101A7 (fi) | Menetelmä 6-hydroksinikotiinihapon valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| FG | Patent granted |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |
|
| MA | Patent expired |